Transforming
the Diagnosis &
Treatment of
Coronary Artery
Disease
CathWorks is dedicated to improving the care of patients suffering from coronary artery disease by using advanced computational science and artificial intelligence to optimize treatment decisions.
Our History
2013
CathWorks founded with a mission to revolutionize the way we understand coronary artery disease to help improve patient outcomes.
2017
FFRangio Validation Study results published in Circulation
2017
CathWorks FFRangio™ System awarded CE Mark
2018
FAST-FFR Pivotal Trial results published in Circulation
2018
FFRangio receives U.S. FDA 510(k) market clearance
2019
CathWorks and FFRangio featured at the 2019 TCT (Transcatheter Cardiovascular Therapeutics) annual meeting
2019
CathWorks FFRangio™ System receives Japan PMDA approval
2020
FFRangio Pooled Analysis results published in the Journal of the American College of Cardiology (JACC)
Innovation is at the Heart of What We Do
CathWorks’ mission is to make data-driven decision-making practical by providing clinicians with objective physiology information for every patient they treat.
Our Team
Our team is driven by the opportunity to partner with physicians and make a difference in the lives of patients.
Our focus is to bring our transformational FFRangio System to clinicians and patients worldwide.
- Founders
- Senior Leadership Team
Ran Kornowski, MD, FESC
Co-Founder
Ramin Mousavi
President & Chief Executive Officer
Duraid Antone
Vice President, Sales &
Physician Training
Mica Mor BenDavid
Vice President, Global Operations &
Finance
Dalit Cohen-Shipperman
Vice President, Global Human Resources
Mike Feher
Chief Financial Officer
Dr. Alex Froimovich
Senior Director, Medical Affairs &
Scientific Communications
Asaf Jazcilevich
Vice President, Research &
Development/Site Leader
Sarita Monico
Senior Director, Global Marketing
Fabian Ngo
Director, Strategy & Advanced Analytics
Ayelet Peer
Vice President, Global
Quality & Regulatory
- Board of Directors
Zafrira Avnur, PhD
Chief Scientific Officer at Quark Venture Inc.
Scott Ward
Chairman of the Board
Andrew ElBardissi
MD Investor, Private Transaction Team, Deerfield Management
Peter Fitzgerald, MD, PhD
Co-Founder of Triventures Fund, Director,
Center of CV Technology, Stanford University
Tomer Kariv
Co-Founder of Pontifax VC
Ramin Mousavi
President & Chief Executive Officer
- Scientific Advisory Board
Bernard De Bruyne, MD, PhD
Director Cardiovascular Center and Catheterization Laboratory
Cardiovascular-Center O.L.V. Ziekenhuis / Belgium
William Fearon, MD
Director, Interventional Cardiology,
Stanford University Medical Center / CA
Stephan Achenbach, MD, FSCCT
Chairman of Cardiology and a Professor of Medicine
at the University of Erlangen / Germany
Ran Kornowski, MD; FESC, FACC; Co-Founder
Chairman, Department of Cardiology
Rabin Medical Center / Israel
President of the Israel Heart Society / ISRAEL
